Umbilical cord tissue cell therapy has been one of the most cutting edge regenerative procedures that is now available.
The umbilical cord tissue is obtained ethically from donors after a scheduled c-section, where the baby and mother are perfectly healthy. There are no embryonic stem cells used in the procedures. The umbilical cord tissue is processed along with Wharton’s Jelly and amniotic fluid at an FDA Certified facility using GMP techniques.
The umbilical cord cell therapies include growth factors, exosomes, cytokines, microRNA and stem cells. Procedures are all outpatient and frequently help patients achieve an increased quality of life. While outcomes vary between individuals, patients often are able to walk farther, participate in recreational activities, breathe easier, sleep better and experience increased energy.
Platelet-rich plasma therapy is the procedure many athletes are undergoing in an effort to treat various conditions including tendonitis, arthritis, chronic joint inflammation, cartilage defects, and muscle strains. Platelet-rich plasma therapy uses the patients’ own blood to control pain and increase functionality.
The blood is centrifuged and separated into three layers – the serum, platelets and white blood cells, and red blood cells. The platelets release over 1,000 biologically active proteins that facilitate tissue regeneration. There have been several human and animal studies that have shown very promising results, such as the 2012 study out of the Hospital for Special Surgery showing its benefit for knee arthritis. Another study showed that a platelet serum injected into a damaged Achilles tendon in a laboratory animal significantly increased tendon strength and stiffness as well as increased tendon strength and fast-twitch responses.
Exosome therapy has been increasing in popularity over the last several years as more research comes out on what they are and what they can do. Interestingly, exosomes are not actually cells, but are cellular byproducts known as extracellular vesicles.
When the exosome is released from a cell (such as a stem cell), it contains significant information from that cell such as DNA and microRNA. As the exosome collides with a new cell and gets ingested, it then transfers that information to the cell. Depending on that cell, the reaction from that information transferred may be a repair response or a “reprogramming” of the cell.
Exosomes have been shown to be safe. No rejection occurs since there are no surface factors, and they cannot divide so tumors have not been seen to date
Have you opened a new location, redesigned your shop, or added a new product or service? Don't keep it to yourself, let folks know.